Atlas Trials

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

Clinical trial NCT03667404 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03667404
Sponsor
Northwestern University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson DiseaseIntestinal Bacteria Flora DisturbanceDietary Modification
Start date
2018-11-06
Primary completion
2022-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.